Financials in USD. Standardized financial statements.
A compact view of how Danimer Scientific, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue? | $46.68M | $53.22M | $58.75M | $47.33M | $32.34M | $30.45M |
| Revenue Growth? | -12.3% | -9.4% | +24.1% | +46.3% | +6.2% | 0.0% |
| Cost of Revenue? | $73.64M | $63.63M | $57.87M | $35.88M | $21.24M | $19.21M |
| Gross Profit? | -$26.96M | -$7.91M | $884,000 | $11.46M | $11.11M | $11.24M |
| Gross Margin? | -57.7% | -14.9% | +1.5% | +24.2% | +34.3% | +36.9% |
| Operating Expenses? | $98.66M | $179.53M | $100.27M | $27.19M | $21.51M | $8.11M |
| Operating Income? | -$125.62M | -$187.43M | -$99.39M | -$15.74M | -$10.40M | -$1.19M |
| EBITDA? | -$96.13M | -$103.49M | -$87.72M | -$1.82M | -$6.89M | $2.35M |
| Income Before Tax | -$155.15M | -$180.57M | -$73.34M | -$8.85M | -$15.43M | $259,000 |
| Income Tax Expense | $319,000 | -$810,000 | -$13.23M | $0 | $4.08M | $51,000 |
| Net Income? | -$155.47M | -$179.76M | -$60.11M | -$8.85M | -$19.51M | $208,000 |
| EPS? | $-1.52 | $-1.78 | $-0.65 | $-0.10 | $-0.41 | $0.07 |
| Diluted EPS? | $-1.52 | $-1.78 | $-0.65 | $-0.10 | $-0.41 | $0.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality